Because the increased cytokine levels in the acute phase of herpes zoster are assumed to be a potential mechanism for inducing PHN, the early suppression of these cytokines by LLLT may help prevent the development of PHN.
Odds of herpes zoster 70% higher among people with respiratory condition.
At willingness-to-pay threshold of 100,000 per QALY, 3 probability of vaccine being cost-effective.
A new analysis pooled patient-level data from 31 randomized, placebo-controlled studies of pregabalin in peripheral NeP.
Pfizer announced results from a phase-3 study evaluating pregabalin controlled-release (CR) formulation in adult patients with postherpetic neuralgia (PHN).
New research highlights the incidence of postherpetic neuralgia (PHN) and its significant burden of disease among elderly patients over time.
Treating this neuropathic pain condition can be complicated because of polypharmacy, drug dosing schedules, adverse events, drug-drug interactions, and patient comorbidities.
Despite the availability of shingles immunization and treatment options, the incidence of postherpetic neuralgia is increasing.
Please login or register first to view this content.
